SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-074096
Filing Date
2011-08-08
Accepted
2011-08-08 07:43:43
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y91416e10vq.htm 10-Q 663164
2 EX-31.1 y91416exv31w1.htm EX-31.1 5966
3 EX-31.2 y91416exv31w2.htm EX-31.2 5980
4 EX-32.1 y91416exv32w1.htm EX-32.1 2297
5 EX-32.2 y91416exv32w2.htm EX-32.2 2091
  Complete submission text file 0000950123-11-074096.txt   8216620

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT mrk-20110630.xml EX-101.INS 1609546
8 EX-101 SCHEMA DOCUMENT mrk-20110630.xsd EX-101.SCH 67344
9 EX-101 CALCULATION LINKBASE DOCUMENT mrk-20110630_cal.xml EX-101.CAL 71159
10 EX-101 LABELS LINKBASE DOCUMENT mrk-20110630_lab.xml EX-101.LAB 525220
11 EX-101 PRESENTATION LINKBASE DOCUMENT mrk-20110630_pre.xml EX-101.PRE 400768
12 EX-101 DEFINITION LINKBASE DOCUMENT mrk-20110630_def.xml EX-101.DEF 283627
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 908-423-4840
Merck & Co. Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 111015662
SIC: 2834 Pharmaceutical Preparations